Researchers sought to determine whether a relationship exists between hypertensive disorders of pregnancy and menopausal symptoms.
The neurokinin 3 receptor antagonist fezolinetant reduces the frequency and severity of vasomotor symptoms in menopause.
Frequent or persistent vasomotor symptoms during the menopause transition are associated with increased risk for later cardiovascular disease events.
Researchers sought to assess the ability of the Fracture Risk Assessment Tool to discriminate between women who do and do not experience major osteoporotic fractures.
Higher estradiol doses had significant benefits for cardiovascular risk factors in early postmenopausal women, but these effects were attenuated in late postmenopausal women.
Researchers sought to determine patient and visit characteristics associated with the discussion of postmenopausal vulvovaginal symptoms at well-woman examinations.